COVID-19 vaccine: SAHPRA endorses FDA decision

A South African health worker holds a dose of COVID-19 vaccine at the Khayelitsha Hospital in Cape Town 


JOHANNESBURG - South Africa's Health Products Regulatory Authority (SAHPRA) has endorsed an FDA decision relating to contaminated vaccines.

The US Food and Drug Administration declared several batches produced at its Baltimore factory unsuitable.

READ: SAHPRA to assess J&J vaccines

SAHPRA has reviewed the FDA's data and agrees those vaccines should not be released.

Two batches were however declared safe for use.

READ: SAHPRA: No major J&J vaccine safety concerns

The US will be sending 300,000 Johnson & Johnson vaccines to South Africa as a matter of extreme urgency.

These vaccines have been cleared for distribution.

SAHPRA still has to assess the safety of the two million J&J jabs stored at the Gqeberha plant.


Paid Content